Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
XPERT® breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results).
Borges PCC, Spencer HB, Barbosa C, Costa V, Furtado A, Leal MC, Lopes C, Ferreira D, Carvalho AL, Dos-Santos-Silva I, Santos LL. Borges PCC, et al. Among authors: costa v. Ecancermedicalscience. 2023 Apr 11;17:1530. doi: 10.3332/ecancer.2023.1530. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37138965 Free PMC article.
Fellowship in surgical oncology: The results of an experience in Portuguese-speaking African countries.
Santos LL, Nhampule R, Vazquez N, Lobito S, Rosa NC, Morais A, Costa V, Pedro JA, Moreira-Gonçalves D, Costa PM. Santos LL, et al. Among authors: costa v. Eur J Surg Oncol. 2024 Jan;50(1):107262. doi: 10.1016/j.ejso.2023.107262. Epub 2023 Nov 10. Eur J Surg Oncol. 2024. PMID: 37979458
We present the results of the fellowship in surgical oncology promoted by the Portuguese Institute of Oncology in Porto (IPO), Fernando Pessoa University, Portugal, and the Calouste Gulbenkian Foundation, which involved the training of residents and surgeons from Portugues …
We present the results of the fellowship in surgical oncology promoted by the Portuguese Institute of Oncology in Porto (IPO), Fernan …